{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:13:01Z","timestamp":1786119181244,"version":"build-2736575974"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1097\/mop.0b013e328306eba1","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T15:11:13Z","timestamp":1236265873000},"page":"413-418","source":"Crossref","is-referenced-by-count":3,"title":["An update on selected connective tissue diseases in adolescents"],"prefix":"10.1097","volume":"20","author":[{"given":"David G","family":"Gamboa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L","family":"Sugarman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210206","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/ard.52.3.169","article-title":"Assessment of lupus: where are we now?","volume":"52","author":"Hay","year":"1993","journal-title":"Ann Rheum Dis"},{"key":"R2-9-20210206","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yadr.2006.08.003","article-title":"Skin signs of systemic disease in childhood","volume":"22","author":"Gilliam","year":"2006","journal-title":"Adv Dermatol"},{"key":"R3-9-20210206","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1136\/ard.57.8.456","article-title":"Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults","volume":"57","author":"Font","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"R4-9-20210206","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1093\/rheumatology\/34.9.866","article-title":"Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome","volume":"34","author":"Tucker","year":"1995","journal-title":"Br J Rheumatol"},{"key":"R5-9-20210206","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1191\/096120399678847704","article-title":"Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. LUpus in MInority populations: NAture vs. Nurture","volume":"8","author":"Alarcon","year":"1999","journal-title":"Lupus"},{"key":"R6-9-20210206","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum"},{"key":"R7-9-20210206","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"R8-9-20210206","first-page":"83","article-title":"Evaluation of the 1982 ARA lupus criteria data set in pediatric patients. Committees of Pediatric Rheumatology of the Brazilian Society of Pediatrics and the Brazilian Society of Rheumatology","volume":"12","author":"Ferraz","year":"1994","journal-title":"Clin Exp Rheumatol"},{"key":"R9-9-20210206","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jpeds.2004.12.045","article-title":"Initial presentation of childhood-onset systemic lupus erythematosus: a French multicenter study","volume":"146","author":"Bader-Meunier","year":"2005","journal-title":"J Pediatr"},{"key":"R10-9-20210206","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1177\/0961203307080636","article-title":"Distinctive clinical features of pediatric systemic lupus erythematosus in three different age classes","volume":"16","author":"Pluchinotta","year":"2007","journal-title":"Lupus"},{"key":"R11-9-20210206","first-page":"2112","article-title":"Predictors of lipid abnormalities in children with new-onset systemic lupus erythematosus","volume":"34","author":"Tyrrell","year":"2007","journal-title":"J Rheumatol"},{"key":"R12-9-20210206","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/art.22691","article-title":"Prevalence and etiology of low bone mineral density in juvenile systemic lupus erythematosus","volume":"56","author":"Compeyrot-Lacassagne","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R13-9-20210206","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/art.23005","article-title":"Initial validation of the pediatric automated neuropsychological assessment metrics for childhood-onset systemic lupus erythematosus","volume":"57","author":"Brunner","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R14-9-20210206","first-page":"525","article-title":"Cardiopulmonary involvement in pediatric systemic lupus erythematosus: a twenty-year retrospective analysis","volume":"40","author":"Yeh","year":"2007","journal-title":"J Microbiol Immunol Infect"},{"key":"R15-9-20210206","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/ni0901-764","article-title":"Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity","volume":"2","author":"Lipsky","year":"2001","journal-title":"Nat Immunol"},{"key":"R16-9-20210206","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.rdc.2005.09.007","article-title":"New therapies for systemic lupus erythematosus: cellular targets.","volume":"32","author":"Looney","year":"2006","journal-title":"Rheum Dis Clin North Am"},{"key":"R17-9-20210206","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1002\/art.20430","article-title":"B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I\/II dose-escalation trial of rituximab","volume":"50","author":"Looney","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R18-9-20210206","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/art.20858","article-title":"Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down-regulation of the T cell costimulatory molecule CD40 ligand: an open-label trial","volume":"52","author":"Sfikakis","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R19-9-20210206","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00467-007-0694-9","article-title":"Rituximab therapy for juvenile-onset systemic lupus erythematosus","volume":"23","author":"Nwobi","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"R20-9-20210206","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jaad.2005.10.041","article-title":"A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis sine myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies","volume":"54","author":"Gerami","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"R21-9-20210206","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/art.23299","article-title":"Persistent association of nailfold capillaroscopy changes and skin involvement over thirty-six months with duration of untreated disease in patients with juvenile dermatomyositis","volume":"58","author":"Christen-Zaech","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R22-9-20210206","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1590\/S0021-75572008000100012","article-title":"Risk factors associated with calcinosis of juvenile dermatomyositis","volume":"84","author":"Sallum","year":"2008","journal-title":"J Pediatr"},{"key":"R23-9-20210206","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1093\/rheumatology\/kem179","article-title":"The Cutaneous Assessment Tool: development and reliability in juvenile idiopathic inflammatory myopathy","volume":"46","author":"Huber","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"R24-9-20210206","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1002\/art.22216","article-title":"Immunogenetic risk and protective factors for juvenile dermatomyositis in Caucasians","volume":"54","author":"Mamyrova","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R25-9-20210206","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ana.20464","article-title":"Interferon-alpha\/beta-mediated innate immune mechanisms in dermatomyositis","volume":"57","author":"Greenberg","year":"2005","journal-title":"Ann Neurol"},{"key":"R26-9-20210206","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1002\/art.22928","article-title":"Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis","volume":"56","author":"Walsh","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R27-9-20210206","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.clim.2006.05.011","article-title":"MxA gene expression in juvenile dermatomyositis peripheral blood mononuclear cells: association with muscle involvement","volume":"120","author":"O'Connor","year":"2006","journal-title":"Clin Immunol"},{"key":"R28-9-20210206","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/art.21031","article-title":"Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease","volume":"52","author":"Kirou","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R29-9-20210206","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/01.bor.0000240362.32089.4c","article-title":"Advances in the treatment of juvenile dermatomyositis","volume":"18","author":"Stringer","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"R30-9-20210206","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jaad.2007.08.014","article-title":"Leflunomide as adjuvant treatment of dermatomyositis","volume":"58","author":"Boswell","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"R32-9-20210206","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1002\/art.22856","article-title":"Rituximab for the treatment of juvenile dermatomyositis: a report of four pediatric patients","volume":"56","author":"Cooper","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R33-9-20210206","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jbspin.2007.05.011","article-title":"Successful treatment of cardiac involvement in dermatomyositis with rituximab","volume":"75","author":"Touma","year":"2007","journal-title":"Joint Bone Spine"},{"key":"R34-9-20210206","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jaad.2006.10.959","article-title":"En coup de sabre morphea and Parry-Romberg syndrome: a retrospective review of 54 patients","volume":"56","author":"Tollefson","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"R35-9-20210206","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1002\/art.21264","article-title":"Localized scleroderma in childhood is not just a skin disease","volume":"52","author":"Zulian","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R37-9-20210206","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1136\/bjo.2007.116038","article-title":"Ocular involvement in children with localised scleroderma: a multicentre study","volume":"91","author":"Zannin","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"R38-9-20210206","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/sj.jid.5700517","article-title":"Cutaneous gene expression by DNA microarray in murine sclerodermatous graft-versus-host disease, a model for human scleroderma","volume":"127","author":"Zhou","year":"2007","journal-title":"J Invest Dermatol"},{"key":"R39-9-20210206","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1546-0096-5-22","article-title":"Increased serum levels of TGFbeta1 in children with localized scleroderma","volume":"5","author":"Uziel","year":"2007","journal-title":"Pediatr Rheumatol Online J"},{"key":"R40-9-20210206","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/rheumatology\/kei251","article-title":"Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study","volume":"45","author":"Zulian","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"R41-9-20210206","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2133.2007.07971.x","article-title":"First case series on the use of calcipotriol-betamethasone dipropionate for morphoea","volume":"157","author":"Dytoc","year":"2007","journal-title":"Br J Dermatol"},{"key":"R42-9-20210206","first-page":"609","article-title":"Treatment of pediatric localized scleroderma with methotrexate","volume":"33","author":"Fitch","year":"2006","journal-title":"J Rheumatol"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MOP.0b013e328306eba1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:44:36Z","timestamp":1786038276000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00008480-200808000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0b013e328306eba1","relation":{},"ISSN":["1040-8703"],"issn-type":[{"value":"1040-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}